Breast cancer drug increases survival

07 Jun 2016


Presented at the American Society of Clinical Oncology, results from a clinical trial of Pfizer's CDK inhibitor palbociclib.

BBC News


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story